Colin Reisner

Colin Reisner

Amministratore Delegato presso
Pearl Therapeutics, Inc.
Health Technology
Consumer Services
Commercial Services

Profilo

Colin Reisner is currently Chief Executive Officer at Pearl Therapeutics, Inc. since 2007 and a Member of the American Thoracic Society, Inc. Former positions include Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Head-Clinical Respiratory at AstraZeneca PLC, Assistant Consulting Professor at Duke University, Assistant Consulting Professor at Yale University, and Principal at Boehringer Ingelheim Corp.
Education includes undergraduate studies at the University of the Witwatersrand.

Posizioni attive di Colin Reisner

SocietàPosizioneInizio
Amministratore Delegato 01/10/2007
Corporate Officer/Principal -

Precedenti posizioni note di Colin Reisner

SocietàPosizioneFine
ASTRAZENECA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Colin Reisner

Formazione di Colin Reisner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

30

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. Colin Reisner